Get started
Author

Shi Ding

Observed names: Ding Shi, S. DING, S. Ding
Institutions: Liaoning University, Chengde Medical University, Xijing Hospital, First Affiliated Hospital Zhejiang University, State Key Laboratory of Diagnosis and Treatment of Infectious Diseases, Zhejiang University, Air Force Medical University
Observed institutions: Liaoning University, Agriculture and Agri-Food Canada, Chengde Medical University, Chinese Academy of Sciences, Shanghai Institutes for Biological Sciences, Shanghai Institute of Materia Medica, NutritionQuest (United States), Xijing Hospital, First Affiliated Hospital Zhejiang University, Lethbridge Research and Development Centre, State Key Laboratory of Drug Research, State Key Laboratory of Diagnosis and Treatment of Infectious Diseases, Zhejiang University, Air Force Medical University
ORCID: 0000-0002-8027-2027
Observed ORCIDs: 0000-0002-8027-2027, 0009-0005-2518-3389
OpenAlex ID: A5101423197
Design, synthesis and biological evaluation of novel N-[4-(2-fluorophenoxy)pyridin-2-yl]cyclopropanecarboxamide derivatives as potential c-Met kinase inhibitors
2020 · Ju Liu, Yilin Gong, et al. · European Journal of Medicinal Chemistry · 52
Design, Synthesis, and Structure–Activity and Structure–Pharmacokinetic Relationship Studies of Novel [6,6,5] Tricyclic Fused Oxazolidinones Leading to the Discovery of a Potent, Selective, and Orally Bioavailable FXa Inhibitor
2014 · Tao Xue, Shi Ding, et al. · Journal of Medicinal Chemistry · 49
Recent advances in c-Met-based dual inhibitors in the treatment of cancers
2024 · Fanqi Jin, Yihan Lin, et al. · European Journal of Medicinal Chemistry · 31
Design, synthesis and biological evaluation of novel osimertinib derivatives as reversible EGFR kinase inhibitors
2022 · Shi Ding, Ziye Gao, et al. · European Journal of Medicinal Chemistry · 30
Design, synthesis and biological evaluation of novel 4-phenoxypyridine based 3-oxo-3,4-dihydroquinoxaline-2-carboxamide derivatives as potential c-Met kinase inhibitors
2020 · Zhen Wang, Jiantao Shi, et al. · Bioorganic Chemistry · 23
Design, synthesis, and structure–activity relationship studies of conformationally restricted mutilin 14-carbamates
2011 · Liqiang Fu, Xin Liu, et al. · Bioorganic & Medicinal Chemistry Letters · 23
Design, synthesis and biological evaluation of novel N-(3-amino-4-methoxyphenyl)acrylamide derivatives as selective EGFRL858R/T790M kinase inhibitors
2021 · Shi Ding, Xiaoyong Dong, et al. · Bioorganic Chemistry · 20
Design, synthesis and structure-activity relationship evaluation of novel LpxC inhibitors as Gram-negative antibacterial agents
2017 · Shi Ding, Rui-Yang Dai, et al. · Bioorganic & Medicinal Chemistry Letters · 18
The Role of FTO in Tumors and Its Research Progress
2021 · Hao Wei, Zhen Li, et al. · Current Medicinal Chemistry · 17
Synthesis and structure–activity relationship studies of novel [6,6,5] tricyclic oxazolidinone derivatives as potential antibacterial agents
2015 · Tao Xue, Shi Ding, et al. · Bioorganic & Medicinal Chemistry Letters · 17
Novel 4-phenoxypyridine derivatives bearing imidazole-4-carboxamide and 1,2,4-triazole-3-carboxamide moieties: Design, synthesis and biological evaluation as potent antitumor agents
2022 · Ju Liu, Fang Liu, et al. · Bioorganic Chemistry · 14
Impact of strain and dose of live yeast and yeast derivatives on in vitro ruminal fermentation of a high-grain diet at two pH levels
2018 · P.X. Jiao, Z.X. He, et al. · Canadian Journal of Animal Science · 14
Dexmedetomidine inhibits ferroptosis through the Akt/GSK3β/Nrf2 axis and alleviates adriamycin-induced cardiotoxicity
2025 · Xuefeng Cao, Liang Zhao, et al. · Life Sciences · 11
Exploration of the structure–activity relationship and druggability of novel oxazolidinone‐based compounds as Gram‐negative antibacterial agents
2019 · Shi Ding, Jing‐Chao Ji, et al. · Archiv der Pharmazie · 11
Advances in Drug Therapy for Systemic Lupus Erythematosus
2020 · Xinghua Zhao, Jiaojiao Zhang, et al. · Current Medicinal Chemistry · 9
Design, synthesis, and biological evaluation of novel thieno[3,2- d ]pyrimidine derivatives as potent antitumor agents
2023 · Yadong Zhang, Jiwei Shen, et al. · New Journal of Chemistry · 8
Study on the Slow-Release Mometasone Furoate Injection of PLGA for the Treatment of Knee Arthritis
2020 · Yutong Liang, Jiaojiao Zhang, et al. · Current Drug Delivery · 8
Design, synthesis and biological evaluation of LpxC inhibitors with novel hydrophilic terminus
2015 · Shi Ding, Wen-Ke Wang, et al. · Chinese Chemical Letters · 8
Charge-Reversal Near-Infrared II Polymeric Amphiphiles Enable Efficient Combinatorial Gene and Mild Photothermal Therapy for Osteosarcoma
2026 · Fang Tang, Xiaoyu Zhang, et al. · ACS Nano · 7
Design, synthesis and biological evaluation of imine-containing inhibitors against the triple-mutant EGFR kinases based on the scaffold of osimertinib
2025 · Shi Ding, Yuanyu Wu, et al. · Bioorganic Chemistry · 6
Research Progress on the Drug Resistance of ALK Kinase Inhibitors
2021 · Zhen Li, Fang Liu, et al. · Current Medicinal Chemistry · 6
Synthesis, Crystal Structure and Antitumour Activity of Ethyl 2-[(2-Amino-3-Cyano-4-Phenethyl-4 H -Naphtho[1,2-b]Pyran-8-yl)Oxy]acetate
2018 · Ju Liu, Jian-Tao Shi, et al. · Journal of Chemical Research · 6
Structural characteristics and SARs of EZH2 inhibitors
2025 · Ruosong Qin, Baohong Ma, et al. · Molecular Diversity · 5
Research Progress on Small Molecules Inhibitors Targeting TRK Kinases
2022 · Ju Liu, Yadong Zhang, et al. · Current Medicinal Chemistry · 5
Design, synthesis, and biological evaluation of novel 4‐phenoxypyridine derivatives as potential antitumor agents
2019 · Ju Liu, Yutong Liu, et al. · Archiv der Pharmazie · 5
Works count: 50
Citation count: 429
H-index: 12
I10-index: 14
Year
Topic
Type